Vietnam holds potential for the development of clinical research and large-scale pharmaceutical production and Abbott will continue its long-term investment in the country, Mr. Robert Ford, Chairman of the Board and CEO at Abbott, said during a reception by Prime Minister Pham Minh Chinh in Hanoi on August 5, the Government News reported.

He said he has been impressed by Vietnam’s development, especially in post-pandemic socio-economic recovery and open policies towards enterprises.

Abbott has been operating in Vietnam since 1995 and has two pharmaceutical manufacturing plants.

Prime Minister Chinh proposed that the US group continue to expand its investment and develop Vietnam’s pharmaceutical industry.

He spoke highly of Abbott’s introduction of cutting-edge medical technologies to the country, and asked other businesses from the US and elsewhere to invest further in Vietnam and help the country in the field of nutrition.

The Prime Minister also affirmed that the Vietnamese Government listens to opinions from all enterprises and creates optimal conditions for them to expand their operations, especially in digital transformation, digital economy, manufacturing and processing, healthcare, high-technology, and high-quality human resources training.